Levamisole Hydrochloride

盐酸左旋咪唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevamisole Hydrochloride
Drug Alias NameLevamisol左旋咪唑LevamisolumL-tetramisolErgamisol +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsKidney DiseasesColonic NeoplasmsWarts +[8] 
Global Approved IndicationsColonic NeoplasmsHookworm InfectionsEnterobiasis +[5] 
Approved Indications in ChinaHookworm InfectionsEnterobiasisAscaridida Infections +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesCongoIran +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesInstitut De Recherche Pour Le DeveloppementYichang Humanwell Pharmaceutical Co LtdShandong Boshan Pharmaceutical Co Ltd
Inactive CompaniesJanssen Pharmaceuticals IncShiraz University Of Medical Sciences
Active IndicationsWartsHookworm InfectionsLoiasis +[6] 
Inactive IndicationsKidney DiseasesColonic Neoplasms

Other Information

ATC CodeP02CE01
Related LinksWikipediaDrugBankKEGG